Curocell (XKRX:372320) ROE % Adjusted to Book Value : -8.37% (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Curocell ROE % Adjusted to Book Value?

Curocell's ROE % for the quarter that ended in Dec. 2024 was -124.57%. Curocell's PB Ratio for the quarter that ended in Dec. 2024 was 14.88. Curocell's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -8.37%.

Curocell ROE % Adjusted to Book Value Historical Data

The historical data trend for Curocell's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell ROE % Adjusted to Book Value Chart

Curocell Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-62.34

-5.80

Curocell Quarterly Data
	Dec19	Dec20	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial							-7.05	-7.79	-7.34	-8.89	-8.37

Competitive Comparison of Curocell's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Curocell's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curocell's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curocell's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Curocell's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Curocell ROE % Adjusted to Book Value Calculation

Curocell's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-86.36%	/	14.88
	=	-5.80%

Curocell's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-124.57%	/	14.88
	=	-8.37%

Curocell ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Curocell's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Curocell Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002

Website

https://www.curocellbtx.com

Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell Headlines

No Headlines